DOUG vs ABOS
Comparison between Douglas Elliman Inc (DOUG, Company) and Acumen Pharmaceuticals Inc (ABOS, Company).
DOUG is from the Real Estate sector, while ABOS is from the Healthcare sector.
5-Year PerformanceABOS has outperformed DOUG, delivering a return of -31.4% compared to -32.2%
DOUG vs ABOS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DOUG vs ABOS - Historical Returns
Returns include dividend reinvestment.
DOUG vs ABOS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | DOUG | ABOS |
|---|---|---|
| 2026 | -21.49% | +12.87% |
| 2025 | +45.40% | +14.05% |
| 2024 | -42.61% | -59.34% |
| 2023 | -23.85% | -27.00% |
| 2022 | -61.06% | -19.76% |
| 2021 | -5.19% | -66.37% |
DOUG vs ABOS Drawdown Comparison
The maximum drawdown for DOUG was -90.25%, occurring on Jun 17, 2024. This drawdown has not yet recovered.
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The current DOUG drawdown is -83.23%. The current ABOS drawdown is -88.76%.
| Rank | DOUG | ABOS |
|---|---|---|
| #1 | -90.25% Dec 30, 2021 - Jun 17, 2024 | -95.56% Jul 2, 2021 - Apr 17, 2025 |
Correlation
Correlation between DOUG and ABOS is 0.54 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks